University of California San Francisco
Give to UCSF
For KGO-TV, Dr. Dean Edell explores a number of wrinkle fillers, some temporary, that are growing in popularity. Richard Glogau, MD, UCSF clinical professor of dermatology, talks about injectable fillers, in particular Restylane, and issues around effectiveness and safety. Dr. Glogau says Restylane is a good all-purpose filler that lasts four to six months.
Michael Cabana, MD, MPH, chief of the Department of General Pediatrics at UCSF Children's Hospital, is heading a study to see if asthma and allergies can be prevented by purposely giving germs to newborns to strengthen their immune systems. KGO-TV's Dr. Dean Edell reports on the UCSF research.
Why a physician-scientist — and others like him — might be our best weapon against disease.
Macy's will illuminate thousands of holiday lights on its 85-foot-tall Union Square fir tree on Friday, November 24, with each twinkling light representing a donation to programs for children facing life-threatening illness at UCSF Children's Hospital.
Increasingly, women are the inspiration for and supporters of the women's health initiative at UCSF.
Employees have until Tuesday, Nov. 21, to make changes to their health benefits during open enrollment.
When Titus Chang was an infant, he was diagnosed with aplastic anemia, a life-threatening condition which stopped his body from producing enough blood cells.
On <i>The Week</i>, the weekly news podcast from <i>The Scientist</i>, feature contributor Gail Dutton talks with Steven Deeks, MD, associate clinical professor in the Department of Medicine at UCSF, about "elite controllers," HIV-infected patients who are resistant to the onset of the disease.
A novel method for predicting the risk of prostate cancer recurrence following surgery that was developed by urologists at UCSF Medical Center has been validated in a recent study.
The campus community is invited to view a varied collection of art works on display through Friday on the Parnassus campus.
Cynthia Kim, MD, a pediatrician at UCSF Children's Hospital, talks to KPIX -TV's Dr. Kim Mulvihill about the FDA warning that users of the flu medication Tamiflu should be monitored for reported bizarre side effects.
A study of almost 600,000 men aged 70 and older reveals that 56 percent had a routine prostate-specific antigen (PSA) screening, a blood test for prostate cancer, even though no treatment guidelines recommend PSA screening for men of that age.